Yuan et al. have developed an injectable citrate-based polyester hydrogel for the local sustained delivery of MYDGF in the heart after MI, which resulted in improved cardiac morphology and functionality, increased angiogenesis, and improved cardiomyocytes survival [58]. Here, MYDGF is linked to myocardial infarction.